Results 101 to 110 of about 27,778 (225)

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.

open access: yesPLoS ONE, 2014
BackgroundIL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of ...
Simone Susser   +8 more
doaj   +1 more source

Interferon Side Effects: When Somatization Betrays You - A Case Report [PDF]

open access: yes, 2015
Neuropsychiatric symptoms are widely reported in association with both hepatitis C and IFNα treatment [1]its sequelae, and its treatment. In particular, interferon, a primary component of treatment for chronic hepatitis C, has been strongly associated ...
Domingues, V., França, M., Neves, S.
core  

Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis. [PDF]

open access: yesVirol J, 2023
Shafiee A   +8 more
europepmc   +1 more source

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database

open access: yesDrug Design, Development and Therapy, 2014
Izumi Sato,1 Takuro Shimbo,2 Yohei Kawasaki,3 Naohiko Masaki41Department of Clinical Study and Informatics, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; 2Ohta Nishinouchi Hospital, Fukushima, Japan ...
Sato I, Shimbo T, Kawasaki Y, Masaki N
doaj  

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG) [PDF]

open access: yes, 2017
Background: Combination of temozolomide (TMZ) with nonpegylated interferon alfa is associated with increased efficacy in terms of response rates compared with monotherapy.
Becker, J. C.   +14 more
core  

Tratamiento del linfoma cutáneo de células T con bexaroteno a dosis bajas en combinación con fototerapia o interferon alfa: comunicación de ocho casos tratados en el Hospital Edgardo Rebagliati Martins, 2003-2007, Lima, Perú

open access: yesActa Médica Peruana, 2018
Introducción: bexaroteno es un rexinoide aprobado en el tratamiento de estadios tempranos y avanzados del linfoma cutáneo de células T (LCCT). Caso Clínico: el presente reporte de casos mostramos los resultados del empleo de bexaroteno en dosis bajas ...
Brady Beltrán Gárate   +7 more
doaj  

Efectividad del interferón peguilado alfa 2a más ribavirina para la hepatitis crónica C en la práctica

open access: yesActa Gastroenterológica Latinoamericana, 2010
Antecedentes. En la actualidad el tratamiento estándar y consensuado de la infección crónica por el virus de la hepatitis C se basa en la combinación de dos fármacos: interferón peguilado y ribavirina.
Nelia Hernández   +5 more
doaj  

Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1. [PDF]

open access: yesFront Immunol, 2021
Azamor T   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy